Massachusetts Financial Services CO Kal Vista Pharmaceuticals, Inc. Transaction History

Massachusetts Financial Services CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$12.36 - $18.28 $386,299 - $571,323	-31,254 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$17.11 - $24.49 $211,000 - $302,010	-12,332 Reduced 28.29%	31,254 $545,000
Q2 2021 Aug 13, 2021	BUY	$23.12 - $29.91 $689,646 - $892,185	29,829 Added 216.83%	43,586 $1.04 Million
Q1 2021 May 13, 2021	BUY	$14.69 - $42.57 $202,090 - $585,635	13,757 New	13,757 $353,000

126

47.9M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $227M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.